Pixyl receives FDA clearance for AI-powered brain MRI software Pixyl.Neuro™
GRENOBLE, FRANCE (Nov 20, 2023) – Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro™, the next-generation AI software for brain MRI analysis that recently demonstrated enhanced detection rates up to 28%. Pixyl is an award-winning French medtech specializing in AI-powered MRI solutions to improve patient care. Pixyl.Neuro™ automatically analyzes brain MRI images to support […]
Le Point names Pixyl one of the most innovative companies in France
We are honored to be selected as one of the most innovative companies in France by Le Point ! We are grateful for this recognition of how AI is transforming the field of neuroscience and changing lives for the better! read more
World MS Day 2023
For World MS Day we sat down with the brilliant and inspiring Sarah Connell to talk about her journey with Multiple Sclerosis. Can you tell us about your MS diagnosis? I remember university being the first time I realised there might be something wrong. I had pins and needles in my legs and feet on […]
SFNR 2023 & 1st User Club!
The 50th Congress of the Société Française de Neuroradiologie (SFNR) marked a milestone in the history of Pixyl with our 1st User Club! An occasion to share ideas and insights, explore the benefits and challenges of integrating AI into routine practice, and identify the added value it can bring. The feedback provided by radiologists is integral to our development […]
Pixyl @ RSNA 2022!
We’re thrilled to announce our presence at RSNA 2022 in Chicago! Join us at booth 3949 for an immersive experience of neuroimaging AI in action. Our team can’t wait to demonstrate the latest advancements in this exciting field!
Pixyl and Brainomix team up to expand distribution and reach
Brainomix, an AI-powered medtech solutions company, has announced a new partnership with Pixyl, an award-winning, Grenoble-based medtech specializing in medical neurology imaging. As part of the collaboration, Brainomix will distribute Pixyl’s Neuro.MS Software as a Service (SaaS) solution, which is used in the diagnosis and treatment of patients with multiple sclerosis. Pixyl’s revolutionary deep-learning technology […]
Series A funding to accelerate market expansion and support new product development
English Français
Pixyl partner in groundbreaking
PRIMUS Project
The PRIMUS consortium (Projection in Multiple Sclerosis) will leverage AI driven by extensive clinical and imaging datasets to transform clinical decision support for the treatment of multiple sclerosis. The project was funded as part of the fifth call for RHU proposals under the Future Investments Program (PIA), integrated into France 2030 and operated by the National […]
Pixyl raises € 2.2M to improve patient care by placing the most advanced neuroimaging AI technology in the hands of radiologists and clinicians
English Français
Pixyl partners with GE Healthcare and AP-HP to develop the next generation of AI solutions for healthcare
English Français
